ABC chemotherapy is one of the popular ALK Positive Lung Cancer treatment options widely used around the globe

ALK Positive Lung Cancer is a rare form of non-metastatic cancer that can be treated aggressively with immunotherapy. The most important characteristic of this form of cancer is the presence of a cellular abnormality at the metacentric level in the human lung. This cancer occurs mainly in smokers who have failed to quit and has spread to other parts of the body. As a result, ALK Positive Lung Cancer Treatment involves the use of interferon-gamma, a highly effective viral infection that attacks the cancerous cells.

Several experimental treatments are currently being conducted to find a cure for ALK Positive Lung Cancer. A recent study by the University Of Pennsylvania School Of Medicine shows that crizotinib increases the risk of spontaneous remission in patients with early and advanced stage pulmonary adenocarcinomas. Although the initial results of the study showed an increase in the survival rate of patients, the numbers of patients that died due to complications were too low to be worth noting. This particular study has brought much hope to patients suffering from ALK Positive Lung Cancer. In addition, other research has shown that crizotinib may also slow down the progression of malignant cells. However, more studies need to be conducted to evaluate the effects of crizotinib in patients with advanced-stage pulmonary adenocarcinoma.